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Several medical and psychological factors should be con-
sidered regarding refugees repatriated by aircraft to their
home countries. Traumatized refugees warrant special
concern, but differential treatment among western coun-
tries generates controversy. Austria generally accepts that
traumatized refugees, especially those suffering from post-
traumatic stress disorder (PTSD), should not be subjected
to forced repatriation. Medical professionals can play an
important role in the recognition of the symptoms of
PTSD. The treatment of refugees suffering from PTSD
should be determined by treating physicians – forced
repatriation could lead to retraumatization and worsen-
ing of symptoms. Treatment in the home countries from
which they had fled might not reach acceptable standards
of care.
As the tragic lethal example of Marcus Omofuma [1] in
Austria has shown, there is a major physical risk during
deportations. Physically-immobilized refugees experience
considerable stress; physicians must institute appropriate
preventive measures to protect their health. When medi-
cally appropriate, physicians may prescribe tranquilizers
when requested, with written consent of the patient.
The medical emergency of Paris Airport reported 109
proven pulmonary embolisms between 1990 and 2000,
with 4 deaths in 2000 [2]. Because of the immobilization
of refugees during flight and the general risk of dehydra-
tion, measures should be undertaken to prevent limb
thrombosis. Sarvesvaran reported that 20% of deaths were
caused by pulmonary embolism on arrival at Heathrow
airports, ten times more than on departure [3]. Therefore,
the individual refugee should be informed about the risk
of thrombosis and advised to make movement of the
lower extremities during flight and to drink adequate
amounts of water prior the flight. Further, in subjects at
high risk low-dose aspirin should be considered for pre-
vention of thrombosis and pulmonary embolism [4,5].
Respiratory problems comprise approximately 11% of in-
flight emergencies [6]. The guidelines for assessment of
respiratory diseases are available online at http://
www.brit-thoracic.org.uk[6,7]. Those individuals with a
resting oxygen saturation below 92% or 92–95% on air
with additional risk factors should have a formal hypoxic
challenge test to identify whether they are able to compen-
sate for the altitude. Supplementary oxygen is recom-
mended for those patients whose arterial oxygen pressure
remains below 6.6 kPa (50 mmHg) [7,8].
Finally, the limited space in the aircraft and the poor
health condition of many refugees facilitate the risk of
transmission of respiratory diseases in association with air
travel. For example, transmission of Mycobacterium
tuberculosis may occur more often during flights longer
than eight hours, as the risk of infection is related to the
proximity and duration of exposure to the source patient
[9].
We lament the lack of formal data collection regarding
health status during refugee deportation and repatriation
and emphasize the likely under-reporting of medical com-
plications beyond the few cases reported in the non-med-
ical media. Medical professionals involved in these
processes should institute preventive measures in order to
minimize the possible medical and psychological compli-
cations among these groups of fragile individuals.
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